Emerging Implications of Elevated Lipoprotein(a) Levels in Coronary Artery Bypass Graft Surgery

Shubh K Patel1, Miriam S Badross2, Nitish K Dhingra3

  • 1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

PubMed

Insights

Elevated lipoprotein(a) levels increase risks after coronary artery bypass grafting (CABG). Routine measurement and emerging therapies may improve outcomes for patients with coronary artery disease (CAD).

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Clinical Biochemistry

Background:

  • Coronary artery bypass grafting (CABG) is vital for coronary artery disease (CAD) management.
  • Optimizing modifiable risk factors pre-CABG improves surgical outcomes.
  • Lipoprotein(a) [Lp(a)] is increasingly recognized for its role in ischemic cardiovascular disease and CABG outcomes.

Purpose of the Study:

  • To review the role of Lp(a) in CAD pathogenesis and CABG outcomes.
  • To discuss perioperative management strategies for Lp(a) in CABG patients.

Main Methods:

  • A comprehensive literature search of PubMed/MEDLINE up to March 2024.
  • Inclusion of studies evaluating Lp(a) in relation to CABG surgery and CAD outcomes.

Main Results:

  • Lipoprotein(a) is a causal, independent risk factor for CAD development.
  • Higher Lp(a) levels correlate with adverse post-CABG events, including graft occlusion and major adverse cardiovascular events.
  • Emerging Lp(a)-lowering therapies show potential for improving prognosis after CABG.

Conclusions:

  • Lp(a) levels can stratify risk and guide perioperative management in patients undergoing CABG.
  • Routine Lp(a) measurement is recommended for all CABG candidates.
  • Further research on Lp(a)-lowering agents in cardiac surgery subcohorts is needed to confirm their efficacy in improving CABG outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...